Annual Total Liabilities
$403.46 M
+$65.45 M+19.37%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual total liabilities is $403.46 million, with the most recent change of +$65.45 million (+19.37%) on December 31, 2023.
- During the last 3 years, MCRB annual total liabilities has risen by +$235.27 million (+139.88%).
- MCRB annual total liabilities is now at all-time high.
Performance
MCRB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$154.82 M
-$253.98 M-62.13%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly total liabilities is $154.82 million, with the most recent change of -$253.98 million (-62.13%) on September 30, 2024.
- Over the past year, MCRB quarterly total liabilities has dropped by -$248.63 million (-61.63%).
- MCRB quarterly total liabilities is now -62.13% below its all-time high of $408.81 million, reached on June 30, 2024.
Performance
MCRB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MCRB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.4% | -61.6% |
| 3 y3 years | +139.9% | -54.2% |
| 5 y5 years | +139.4% | -54.2% |
MCRB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.6% | -62.1% | at low |
| 5 y | 5-year | at high | +139.9% | -62.1% | at low |
| alltime | all time | at high | +3406.5% | -62.1% | +3378.4% |
Seres Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $154.82 M(-62.1%) |
| Jun 2024 | - | $408.81 M(+1.9%) |
| Mar 2024 | - | $401.00 M(-0.6%) |
| Dec 2023 | $403.46 M(+19.4%) | $403.46 M(+5.4%) |
| Sep 2023 | - | $382.82 M(-0.2%) |
| Jun 2023 | - | $383.77 M(+20.7%) |
| Mar 2023 | - | $318.06 M(-5.9%) |
| Dec 2022 | $338.00 M(+51.3%) | $338.00 M(+38.4%) |
| Sep 2022 | - | $244.28 M(-2.3%) |
| Jun 2022 | - | $250.14 M(+4.7%) |
| Mar 2022 | - | $238.93 M(+7.0%) |
| Dec 2021 | $223.35 M(+32.8%) | $223.35 M(+1.3%) |
| Sep 2021 | - | $220.56 M(+30.8%) |
| Jun 2021 | - | $168.58 M(+4.1%) |
| Mar 2021 | - | $161.99 M(-3.7%) |
| Dec 2020 | $168.19 M(-7.0%) | $168.19 M(+0.0%) |
| Sep 2020 | - | $168.15 M(+1.1%) |
| Jun 2020 | - | $166.25 M(-3.5%) |
| Mar 2020 | - | $172.27 M(-4.7%) |
| Dec 2019 | $180.76 M | $180.76 M(+15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $156.37 M(-4.7%) |
| Jun 2019 | - | $164.06 M(-7.2%) |
| Mar 2019 | - | $176.88 M(+5.0%) |
| Dec 2018 | $168.52 M(+30.8%) | $168.52 M(+20.7%) |
| Sep 2018 | - | $139.61 M(-4.5%) |
| Jun 2018 | - | $146.21 M(-2.1%) |
| Mar 2018 | - | $149.40 M(+16.0%) |
| Dec 2017 | $128.82 M(-8.0%) | $128.82 M(+1.9%) |
| Sep 2017 | - | $126.37 M(-1.6%) |
| Jun 2017 | - | $128.41 M(-3.7%) |
| Mar 2017 | - | $133.40 M(-4.7%) |
| Dec 2016 | $140.01 M(+1116.9%) | $140.01 M(-2.4%) |
| Sep 2016 | - | $143.52 M(+3.4%) |
| Jun 2016 | - | $138.82 M(+3.1%) |
| Mar 2016 | - | $134.64 M(+1070.2%) |
| Dec 2015 | $11.51 M(-92.0%) | $11.51 M(+137.4%) |
| Sep 2015 | - | $4.85 M(-23.9%) |
| Jun 2015 | - | $6.37 M(+43.1%) |
| Mar 2015 | - | $4.45 M(-96.9%) |
| Dec 2014 | $144.07 M(+988.0%) | $144.07 M |
| Dec 2013 | $13.24 M | - |
FAQ
- What is Seres Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Seres Therapeutics?
- What is Seres Therapeutics annual total liabilities year-on-year change?
- What is Seres Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Seres Therapeutics?
- What is Seres Therapeutics quarterly total liabilities year-on-year change?
What is Seres Therapeutics annual total liabilities?
The current annual total liabilities of MCRB is $403.46 M
What is the all time high annual total liabilities for Seres Therapeutics?
Seres Therapeutics all-time high annual total liabilities is $403.46 M
What is Seres Therapeutics annual total liabilities year-on-year change?
Over the past year, MCRB annual total liabilities has changed by +$65.45 M (+19.37%)
What is Seres Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MCRB is $154.82 M
What is the all time high quarterly total liabilities for Seres Therapeutics?
Seres Therapeutics all-time high quarterly total liabilities is $408.81 M
What is Seres Therapeutics quarterly total liabilities year-on-year change?
Over the past year, MCRB quarterly total liabilities has changed by -$248.63 M (-61.63%)